Working with our partners, we are developing plans to fund new projects in neuroscience, cancer, public health, children’s health and regenerative medicine. To do this we must raise more than £300m in the next five years.
This work is led by our philanthropic development programme managed by our Development Team who would be delighted to speak with you.
We work in close collaboration with the Addenbrooke’s Charitable Trust (ACT) and the Royal Papworth Hospital Charity (PHC) targeting UK, Asia and USA markets for opportunities to develop the following plans:
It’s rare to have the opportunity to create something truly exceptional, with the potential to transform healthcare for children and young people both locally and across the globe. With Cambridge Children’s we have just that: an opportunity to create a new type of children’s hospital, purpose-built to re-imagine the way we think about child health and disease prevention.
Cambridge Children’s will be the first hospital in the world to offer physical and mental health care seamlessly integrated at the bedside, co-located with the world-leading research of the University of Cambridge. This is more than just integrated healthcare; we will be looking to understand the early origins of disease affecting both physical and mental health, to build resilience and improve life trajectories, and to shift from reactive care to prevention.
Our goal is to better detect, understand and delay the onset of physical and mental health conditions; ultimately, to prevent them from ever occurring. We aim to model the hospital of the future, providing a fundamentally new approach to healthcare for children, young people and the adults they become. And we will share and scale our approaches for the benefit of children and families in our region, our country and globally.
The vital importance of Cambridge Children’s has been recognised by the UK Government with a commitment of £100 million towards the project.
Heart and Lung Research Institute
The centrepiece of our strategic response to the global epidemic of cardiovascular disease is the establishment of a new Heart and Lung Research Institute on the Cambridge Biomedical Campus. The Institute is a partnership between the University of Cambridge and Royal Papworth Hospital – the UK’s largest specialist cardiorespiratory hospital and main heart and lung transplant centre. Located right next to the newly relocated Royal Papworth Hospital, which was officially opened by HM The Queen on 9 July 2019, the Institute will bring together world-renowned research and clinical expertise in cardiorespiratory medicine to rapidly translate scientific breakthroughs into new treatments.
The Institute will draw together the highest concentration of heart and lung researchers from academia, healthcare, and industry in Europe. It will be home to over 380 scientists and state-of-the-art laboratories in genomics, population sciences, research into cellular mechanisms of disease, and translational science. It will also include a special ten-bed facility where the first-in-patient studies of new treatments can be conducted.
Research at the new Institute will be increasingly directed towards disease prevention and the interplay between genetics and lifestyle. Clinical trials will be a critical part of the research process, and the Institute will open a new Clinical Research Facility that will complement available facilities on the Biomedical Campus. For many relevant conditions, Royal Papworth is the largest referral centre in the UK, and new treatment strategies will benefit from close ties between the Hospital and the University.
Institute for Brain and Mind Health
The Cambridge Institute of Brain and Mind Health will form the heart of a redeveloped neuroscience district on the Cambridge Biomedical Campus. The district will bring together on a single site hundreds of researchers across multiple disciplines from the University and allied institutions, providing laboratories, clinical research facilities, and educational spaces. This represents a rare opportunity to combine the strengths of clinicians and medical researchers with those of chemists, physicists, engineers, and mathematicians, as well as industry partners, to create the world’s leading centre of excellence dedicated to the development of new therapies for brain and mental health disorders.
Brain and mental health disorders are extremely common and can present at any stage of life – one in four of us will be affected in our lifetimes. It is expected that depression is soon going to be the single biggest cause of disability globally, while 47 million people worldwide are already living with dementia. These disorders have a dramatic effect on quality of life and a profound impact on caregivers, families, and wider society. Across the globe, mental health disorders cost the economy over $2.5 trillion each year, more than cancer and heart disease combined.
We urgently need to discover new treatments, based on an advanced understanding of brain and mind function. It is in response to this pressing global challenge that the University of Cambridge is establishing a dedicated neuroscience district on the Biomedical Campus, concentrating on a single site, in state-of-the-art facilities, our vast and interdisciplinary research network in this field. The new district, centred on the University's Institute for Brain and Mind Health, will allow us to accelerate our unique approach of integrating neuroscience and psychiatry, and of breaking down other traditional disciplinary and conceptual boundaries currently obstructing progress.
Cancer Research Hospital
Here in Cambridge we believe that the only way to make cancer treatment more effective and more sustainable is to change two fundamental variables: detecting cancer earlier and treating it more precisely, matching patients to a course of therapy designed to target the vulnerabilities in their particular cancer at the earliest opportunity. To achieve this vision, the University of Cambridge is partnering with Cambridge University Hospitals NHS Foundation Trust to develop a new type of cancer hospital, which will harness the strength of Cambridge research in the early detection and precision treatment of cancer, and deploy life-saving innovation at-scale and in clinical real-time.
In the Cambridge Cancer Research Hospital, University chemists, physicists, engineers, and mathematicians will work together with doctors to develop and implement new tools, tests, predictive models, and more. From machine-learning experts, using live patient data to help us make better-informed treatment decisions, to engineers undertaking early-phase tests of new detection and monitoring devices, our practice-changing work will be taking place at, or just seconds away from, the patient’s bedside.
It will be a place where more of those patients are cured and where fewer suffer unnecessary treatment side-effects. More radically, we see it as a place where over time fewer will need to occupy those in-patient rooms, or chemotherapy beds, because their cancer will have been found and managed at the earliest possible point of detection, long before more aggressive intervention was required.
Our ambition is that the gains made in Cambridge are extended to patients whose cancer will be diagnosed and treated in other cities and regions, and that our discoveries and innovations become widespread, enduring improvements in cancer treatment and outcomes worldwide.
Supporting Postgraduate Students at Cambridge’s School of Clinical Medicine
Our ambition is to find, mentor, and inspire the most talented and diverse group of young people capable of going on to solve the world's major health challenges. That means ensuring all students with the greatest potential to lead the next generation of world-changing doctors and medical scientists have a chance to study at Cambridge, not just some. It means removing barriers that stand in the way: reaching, supporting, and funding the very best students we can find, from all parts of the UK and the world.
Today's postgraduates are tomorrow's leaders, especially in the field of medicine. Whether in the lab or in the clinic, postgraduates are vital to cutting-edge medical research and practice. If we want to push the boundaries of our knowledge further than ever before, if we are intent on the next great discovery and on transforming the treatment of patients across the globe, then we must ensure that access to higher degrees is not limited to those who can afford them.
We are hugely proud of the strength and breadth of our postgraduate programme in medicine. Our master’s and PhD students are a vital source of fresh eyes, new approaches and bold ideas. Cambridge fosters a culture of radical thinking, and of pursuing solutions to big, unanswered questions. It is to this endeavour that we expect our postgraduate students to contribute – a significant challenge, and a major test of character, but it is also why postgraduate education at Cambridge is the best there is.